Rover Diagnostics Receives $1.8M New York State Biodefense Award
Rover Diagnostics Receives $1.8M New York State Biodefense Award to Develop a Platform for Rapid Diagnostic Development, Response, and Surveillance
New York State Biodefense Commercialization Fund awarded Rover Diagnostics $1.8 million to develop an Affordable and Adaptable real-time Nucleic Acid Amplification Test (NAAT) platform for Rapid Diagnostic Development, Response, and Surveillance.
Since 2019, Rover has been developing the LightSpeed, a sample to answer molecular diagnostic testing solution for use in decentralized settings. The LightSpeed integrates lab based methodologies with multiplex capabilities for future test menu expansion capabilities. The unique technology provides rapid sample processing in
Since 2019, Rover has been developing the LightSpeed, a sample to answer molecular diagnostic testing solution for use in decentralized settings. The LightSpeed integrates lab based methodologies with multiplex capabilities for future test menu expansion capabilities. The unique technology provides rapid sample processing in
- Contact Email
- [email protected]
- Issued By
- Maliha Momtaj
- Phone
- 646-577-0859
- Business Address
- Rover Diagnostics 3960 Broadway, New York, NY 10032
- Country
- United States
- Categories
- Biotech · Health · Medical
- Last Updated
- October 30, 2024